MYLAN (NASDAQ:MYL)
17.68
-0 (-0%)
| MYLAN (NASDAQ:MYL) Delayed : |
| Previous Close |
$17.68 |
|
52 Week High |
$19.21 |
|
| Open |
$17.80 |
|
52 Week Low |
$11.14 |
| Day High |
$17.96 |
|
P/E |
110.50 |
| Day Low |
$17.54 |
|
EPS |
$0.16 |
| Volume |
5,953,376 |
|
|
|
| More MYL Info:
Chart
SEC Filings
Profile
Historical
Options
|
Mylan Inc. Summary
Mylan, Inc. and its subsidiaries engage in the development, manufacture, marketing, licensing, and distribution of generic, brand, and branded generic pharmaceutical products, as well as active pharmaceutical ingredients. The company offers its products in various therapeutic areas, including cardiovascular, central nervous system, dermatology, gastrointestinal, endocrine and metabolic, and renal and ...more
Executives
Milan Puskar - Co Founder & Chairman, Robert J. Coury - Vice Chairman & CEO
Links
http://www.mylan.com
-
Feb 3, 2010 07:44 AM
Oppenheimer Starts Mylan (MYL), Warner Chilcott (WCRX) at Outperform
-
Jan 29, 2010 10:43 AM
Mylan (MYL) Gets OK from U.S. FDA for ANDA for Generic Form of GoLytely
-
Jan 8, 2010 10:51 AM
Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded
-
Jan 8, 2010 08:37 AM
Mylan (MYL) Pre-Paid $196M in Term-Loans Due 2011; Has No Term-Loan Obligations Due in 2012
-
Jan 8, 2010 07:17 AM
Goldman Sachs Downgraded Generics to Neutral; MYL, IPXL Cut to Neutral
View All Reports
StreetInsider Reports on MYL by Category
-
Feb 3, 2010 11:15 AM
Analyst Upgrades, Downgrades and Initiations: ARM, KFT, LOW, OXY, UBS, UPS, VRSN ...
-
Jan 12, 2010 06:47 AM
Cramer's Lightning Round - The Best Generic Drug Stock (1/11/10)
-
Jan 11, 2010 10:06 AM
Johnson & Johnson: My First Pick of 2010
-
Jan 9, 2010 02:28 PM
Mylan: Cashing in on Generic Drugs
-
Dec 29, 2009 04:18 AM
Watson Pharmaceuticals: Look-Ahead to December 2009 Quarterly Results
View All Blogs
Comments on recent MYL articles
Comments on MYL
No comments are currently available.
on Jan 8, 2010
at 07:56 PM INSIDE INFO GS ANALYST FORGET TO LET ME KNOW TOO ON IPXL ON THURSDAY MID DAY
Article: Goldman Sachs Downgraded Generics to Neutral; MYL, IPXL Cut to Neutral
on Jul 28, 2009
at 03:38 PM Check again Except the FDA disagrees with that statement, which is likely why the stock when back down to almost opening levels.
Article: Mylan (MYL) Recovers After Accusations Prove Unfounded
on May 24, 2008
at 09:34 PM dose I was on the Sandoze patches175mcg and I feel they worked better then the mylan patches that I am on now.I stopped using the Sandoze patches because I was getting a rash from the glue or sticky stuff on the edges of the patch that sticks to the skin, I like the Mylan patches because they stay on better and are not as noticable when on me!(Great)! ! ,but I am woundering if the dose is the same because I am in alot more pain now then I was before I switched brands. Can someone tell me if the doese is actualy the same or not?
Article: Mylan (MYL) Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced Feb 12th
on Mar 7, 2008
at 07:42 PM share price lowering I have seen the price of myl stock steadily sink in price after the ceo took a large amount of money for compensation in July.
Article: Mylan (MYL) CEO Buys Another 20K Shares